20 ML chloroprocaine hydrochloride 30 MG/ML Injection [Nesacaine] — RxCUI 992811
RxNorm drug concept · Semantic branded drug
RxCUI 992811
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI992811
Official name20 ML chloroprocaine hydrochloride 30 MG/ML Injection [Nesacaine]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNesacaine 3 % per 20 ML Injection; Nesacaine 3 % in 20 ML Injection; 20 ML Nesacaine 30 MG/ML Injection
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)137 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Chloroprocaine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Chloroprocaine is a local anesthetic — it numbs a specific part of your body so you don't feel pain during a procedure. Depending on the product and strength, it can be used for si...
- What exactly is chloroprocaine used for?
- Yes — chloroprocaine is a local or regional anesthetic, not a general anesthetic. It numbs the targeted area but does not make you unconscious. You'll be awake and aware, just unab...
- Chloroprocaine works quickly — usually within 6 to 12 minutes — and the numbing typically lasts up to about an hour, depending on how much is used and where it's given. It's actual...
🕸️ Concept Web — How 20 ML chloroprocaine hydrochloride 30 MG/ML Inje... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML chloroprocaine hydrochloride 30 MG/ML Injection [Nesacaine]
RxCUI 992811 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Chloroprocaine
20859IN -
Chloroprocaine hydrochloride
53616PIN
-
Chloroprocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nesacaine
225031BN
-
Nesacaine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Chloroprocaine Injection
1794183SCDF -
Chloroprocaine hydrochloride Injection
2646227SCDFP -
Chloroprocaine Injectable Product
1162453SCDG -
Chloroprocaine hydrochloride Injectable Product
2661880SCDGP -
Chloroprocaine Injection [Nesacaine]
1794185SBDF -
Chloroprocaine hydrochloride Injection [Nesacaine]
2656799SBDFP -
Nesacaine Injectable Product
1182275SBDG -
Injection
1649574DF - +1 more in this family
-
Chloroprocaine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
20 ML chloroprocaine hydrochloride 30 MG/ML Injection
992809SCD -
Chloroprocaine hydrochloride 30 MG/ML
992808SCDC -
Chloroprocaine hydrochloride 30 MG/ML [Nesacaine]
992810SBDC
-
20 ML chloroprocaine hydrochloride 30 MG/ML Injection
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
20 ML chloroprocaine hydrochloride 30 MG/ML Injection
SCD · 992809 -
Chloroprocaine hydrochloride 30 MG/ML
SCDC · 992808 -
Chloroprocaine Injection
SCDF · 1794183 -
Chloroprocaine hydrochloride Injection
SCDFP · 2646227 -
Chloroprocaine Injectable Product
SCDG · 1162453 -
Chloroprocaine hydrochloride Injectable Product
SCDGP · 2661880
Brand-Name Concepts
-
Chloroprocaine hydrochloride 30 MG/ML [Nesacaine]
SBDC · 992810 -
Chloroprocaine Injection [Nesacaine]
SBDF · 1794185 -
Chloroprocaine hydrochloride Injection [Nesacaine]
SBDFP · 2656799 -
Nesacaine Injectable Product
SBDG · 1182275 -
Nesacaine
BN · 225031
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 992811 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 63323-0475-37 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-475-37) / 30 mL in 1 V... | Nesacaine | Fresenius Kabi USA, LLC | 2010-10-14 |
| 63323-0476-37 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-476-37) / 30 mL in 1 V... | Nesacaine | Fresenius Kabi USA, LLC | 2010-10-14 |
| 63323-0477-27 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-477-27) / 20 mL in 1... | Nesacaine MPF | Fresenius Kabi USA, LLC | 2010-10-14 |
| 63323-0478-27 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-478-27) / 20 mL in 1... | Nesacaine MPF | Fresenius Kabi USA, LLC | 2010-10-14 |
Observed labelers:
Fresenius Kabi USA, LLC (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2401 | Chloroprocaine hcl injection | 4 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.